Natural product-derived PD-1 pathway blockade for Human cancer therapy: Nectandrin B, isolated from Nutmeg, decreases the activity of Glycogen synthase kinase-3β, increases transcription factor T-bet expression, decreases the abundance of co-inhibitory receptor PD-1 on the cell surface of Cytotoxic-T-cells, increases cytotoxic T lymphocyte function and augments anti-tumor activity, via up-regulation of its target gene, 21/April/2017, 6.21 am

Natural product-derived therapy therapy for Stroke: Nectandrin B, a Nutmeg lignan, attenuates hippocampal neurons injury and ameliorates stroke damage and neurological deficits via up regulation of its target gene BDNF., 20/April/2017, 11.13 pm
April 20, 2017
Antiviral therapy for HIV virus: 15-Deoxy-Δ12,14 Prostaglandin J2 (15d-PGJ2) increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1 Gag protein, disrupts HIV-1 budding, and restricts HIV-1 production via up regulation of its target gene, 21/April/2017, 4.03 pm
April 21, 2017
Show all

Introduction:What they say

A recent study from Cell Signalling Section, Division of Immunology, Department of Pathology, Tennis Court Road, University of Cambridge, Cambridge CB2 1QP, UK shows that “Glycogen Synthase Kinase 3 Inactivation Drives T-bet-Mediated Downregulation of Co-receptor PD-1 to Enhance CD8(+) Cytolytic T Cell Responses.” This study was published in the 16 February 2016 issue of Immunity (one of the best journals in Immunology with an impact factor of 20+) by Prof Rudd CE, Taylor A and others.


What we say

price-50

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-derived PD-1 pathway blockade for Human cancer therapy: Nectandrin B, isolated from Nutmeg, decreases the activity of Glycogen synthase kinase-3β, increases transcription factor T-bet expression, decreases the abundance of co-inhibitory receptor PD-1 on the cell surface of Cytotoxic-T-cells, increases cytotoxic T lymphocyte function and augments anti-tumor activity, via up-regulation of its target gene


What is known?

It has recently been shown that blocking PD-1 with antibodies one could make tumors shrink. This work, relating to Cancer immunotherapy, has been chosen as Science’s breakthrough of the year.


Research Findings

This study suggests a natural product-derived therapy for human cancers. Nectandrin Bby inhibiting the activity of Glycogen synthase kinase 3-β (fig 1), it may: (a) increase transcription factor T-bet expression; (b) inhibit co-inhibitory receptor PD-1 expression;  (c) increase CD8(+) cytotoxic T lymphocyte function; (d) augment anti-tumor activity; & (e) inhibit metastatic cancer progression (figs. 1-3).

Nectandrin B க்கான பட முடிவு

Fig 1 Nectandrin B serves as an anti-tumor immunity booster. Nectandrin B increases T-bet expression, inhibits PD-1 expression, and augments anti-tumor immunity

nutmeg tree க்கான பட முடிவு

Figure 2. Nutmeg tree

தொடர்புடைய படம்

Figure 3. Nutmeg. Nectandrin B, found in Nutmeg, augments anti-tumor immunity via down regulation of PD-1


Therapeutic opportunity

Thus, pharmacological formulations encompassing Nectandrin B  or its analogues either alone or in combination with other drugs may be used to inhibit the progression of tumors.


Details of the research findings:

Idea Proposed/Formulated (with experimental evidence) by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Amount: $50

Undisclosed mechanistic information: How does  Nectandrin B suppress the expression of PD-1 to promote anti-tumor immunity?

# Research cooperation

For purchase and payment information, you may reach us at admin@genomediscovery.org


References:

Citation: Boominathan, L., Natural product-derived PD-1 pathway blockade for Human cancer therapy: Nectandrin B, isolated from Nutmeg, decreases the activity of Glycogen synthase kinase-3β, increases transcription factor T-bet expression, decreases the abundance of co-inhibitory receptor PD-1 on the cell surface of Cytotoxic-T-cells, increases cytotoxic T lymphocyte function and augments anti-tumor activity, via up-regulation of its target gene, 21/April/2017,  6.21 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org or http://newbioideas.com/

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.